Ottawa Heart Institute Research Corporation
Clinical trials sponsored by Ottawa Heart Institute Research Corporation, explained in plain language.
-
Online coach aims to get heart patients moving
Disease control CompletedThis study tests whether a web-based coaching program called CardioFit can help people with coronary artery disease become more physically active. Participants use a secure website to create personalized exercise plans with guidance from an online coach. The trial compares Cardio…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
Robot calls could help heart patients kick the habit
Disease control CompletedThis study tests whether an automated phone system that calls smokers with coronary heart disease after hospital discharge can help them quit. Participants receive calls at several time points over six months, checking on their smoking and offering support. The goal is to see if …
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
Does a diabetes specialist team beat standard care for heart patients?
Disease control CompletedThis study tested whether a team of specialists—an endocrinologist, diabetes educator, and dietician—could help people with type 2 diabetes and heart disease control their blood sugar better than standard care. 169 patients were split into two groups: one received usual care from…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Heart patients get new hope: varenicline vs. nicotine patch in quitting smoking
Disease control CompletedThis pilot study tested whether varenicline (Chantix) helps smokers with coronary heart disease quit better than the standard nicotine patch. Fifty motivated smokers who had a heart-related event were randomly assigned to one of the two treatments for 12 weeks. The main goal was …
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New initiative aims to boost heart failure drug use in device patients
Disease control CompletedThis study tested a new way to help heart failure patients with weak hearts get the right medications. Over 2,400 people with a heart device took part. A nurse used a simple checklist to guide doctors in prescribing better treatments, aiming to reduce hospital visits and improve …
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Heart procedure may beat drugs for AFib patients with heart failure
Disease control CompletedThis study tested whether catheter ablation (a procedure to fix irregular heart rhythm) is better than standard rate-control medication for people with both atrial fibrillation and heart failure. Over 400 participants were randomly assigned to either ablation or medication. The m…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Old drug, new hope for right heart failure?
Disease control CompletedThis study tested the drug spironolactone in 15 adults with chronic right-sided heart failure. The goal was to see if it is safe and can improve heart function and reduce stress on the heart. Participants took either the drug or a placebo to compare effects.
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New home blood pressure program aims to tame hypertension remotely
Disease control CompletedThis study tested a remote telehome monitoring program for 100 people with high blood pressure who receive virtual care. Participants used a special blood pressure cuff and a monitoring platform to share readings with their doctors. The goal was to see if this approach improves b…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a gout drug slow a stiff heart valve?
Disease control CompletedThis pilot study tested whether colchicine, an anti-inflammatory drug, can slow the buildup of calcium in the aortic valve. 24 adults with mild-to-moderate aortic stenosis were randomly assigned to take colchicine or a placebo for 6 months. The study measured changes in valve cal…
Phase: PHASE2, PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hybrid rehab could help PAD patients walk farther and protect their hearts
Disease control CompletedThis pilot study tested a hybrid rehabilitation program for people with peripheral arterial disease (PAD), a condition that causes leg pain and limits walking. The program combines a few on-site supervised sessions with a home-based walking plan to make it easier for patients to …
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail aims to cut bleeding and heart attacks in atrial fibrillation patients
Disease control CompletedThis study tested a combination of two drugs, rivaroxaban and ticagrelor, in 40 patients with atrial fibrillation who had a stent placed. The goal was to see if this combo causes less bleeding and prevents heart attacks or strokes better than current treatments. Patients took the…
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Simple breathing workout may boost heart health
Disease control CompletedThis study tested whether a breathing muscle training device could improve blood flow in the hearts of people with coronary artery disease. Forty participants used the device daily for six weeks. Researchers compared high-intensity versus low-intensity training to see if it incre…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a gout drug cool down artery inflammation in diabetics?
Disease control CompletedThis study tested whether colchicine, a drug used for gout, can reduce inflammation in the arteries of people with diabetes who recently had a heart attack or stroke. Researchers used a special PET scan to measure inflammation in the blood vessels. 115 participants were randomly …
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a Dual-Chamber device shrink an enlarged heart in AF patients?
Disease control CompletedThis study looked at 200 people with both heart failure and permanent atrial fibrillation. Participants received either a standard defibrillator (ICD) or one that also paces both lower heart chambers (CRT/ICD). The goal was to see if the extra pacing reduces heart size and improv…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Blood pressure drugs tested as COVID-19 treatment in global trial
Disease control CompletedThis study tested whether common blood pressure medications (ACE inhibitors or ARBs) could improve outcomes for high-risk COVID-19 patients. Researchers enrolled 372 adults with confirmed COVID-19 who were either over 40 (outpatients) or over 18 (hospitalized). The goal was to se…
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Which blood thinner best prevents stroke after AF ablation?
Disease control CompletedThis trial tested two blood thinners—rivaroxaban (Xarelto) and aspirin—in over 1,200 people with atrial fibrillation who had a successful ablation procedure. The goal was to see which one better prevents strokes and silent brain clots. Participants were followed for three years w…
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a 12-Week lifestyle program slash heart risk in families?
Prevention CompletedThis trial tests whether a 12-week program led by a heart health educator can lower cholesterol and improve heart health in spouses, siblings, and children of people hospitalized with coronary heart disease. Participants work with an educator to create a personal plan for smoking…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Prevention
Last updated Jul 01, 2026 23:00 UTC
-
Couples therapy for heart patients? new program aims to heal hearts together
Symptom relief CompletedThis completed trial tested an 8-week program called Healing Hearts Together (HHT) for couples where one partner has heart disease. 474 couples attended weekly group sessions focused on communication, emotional support, and heart health. The goal was to see if the program improve…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Heart device study tests virtual workouts for Women's health
Symptom relief CompletedThis study looked at whether a 12-week virtual exercise program could help women with cardiac implantable electronic devices (CIEDs) improve their physical fitness, quality of life, and mental health. Twenty women took part, doing either high-intensity interval training (HIIT) or…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Small study tests if exercise eases heart flutter symptoms
Knowledge-focused CompletedThis pilot study looked at whether it's possible to run a larger trial comparing two types of exercise—moderate steady exercise and high-intensity interval training—on symptoms of atrial fibrillation (AF), a common heart rhythm problem. Researchers enrolled 25 men and women with …
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Heart valve study: which blood thinner best protects the brain?
Knowledge-focused CompletedThis study looked at 70 people who had a tissue heart valve replacement. It compared two common blood-thinning treatments (high-dose aspirin alone vs warfarin plus low-dose aspirin) to see which one better prevented tiny blood clots from traveling to the brain. Researchers used u…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Heart MRI may reveal who really needs a shock device
Knowledge-focused CompletedThis study looked at 502 people with heart failure who were getting an implantable defibrillator (ICD) to prevent sudden cardiac arrest. Researchers used a special MRI to see if heart scarring patterns could predict who would later need a shock from the device. The goal was to le…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Vitamin d deficiency common in heart failure patients – does supplementation help?
Knowledge-focused CompletedThis study looked at how common vitamin D deficiency is in people with chronic heart failure and whether giving vitamin D supplements improves their health. 91 adults with heart failure were divided into groups based on their vitamin D levels. Those with severe deficiency were ra…
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Blood markers may reveal hidden stroke risk in heart patients
Knowledge-focused CompletedThis study looked at 321 people with pacemakers or heart monitors who had short, symptomless episodes of atrial fibrillation (silent AF). Researchers measured certain proteins in the blood to see if they could predict who might later have a stroke or other heart problems. The goa…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Heart treatment may boost brain chemical, study hints
Knowledge-focused CompletedThis study looked at 200 people with atrial fibrillation to see if treatments like catheter ablation or exercise training change levels of a brain chemical called BDNF. Researchers also checked if these changes relate to mood and quality of life. The goal was to gather knowledge,…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC